Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial.
about
Targeted therapy of gastrointestinal stromal tumoursEmerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future DirectionsAutoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.State of the Art in the Treatment of Gastrointestinal Stromal Tumors.Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.Masitinib for the treatment of mild to moderate Alzheimer's disease.Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review.Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib.Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies.Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis.Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib.Emerging drugs for the treatment of gastrointestinal stromal tumour.New targets and therapies for gastrointestinal stromal tumors.[Advanced gastrointestinal stromal tumors : What role does surgery currently play in multimodal concepts?].Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches.Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.Advances and Challenges on Management of Gastrointestinal Stromal Tumors.
P2860
Q26745633-886AC6B1-AF7C-4CDD-97D6-7AF4222A3156Q26799387-7452E778-7DDD-4BA7-9055-0CE68FC2016EQ36085618-9EBE834F-28CE-43B6-B9C3-9A356501BC20Q36125976-E60D78F5-48E8-453E-A69B-65E2601FB692Q36344557-47445F2C-FB82-4204-964B-C07EE3A96843Q38323440-8B6699AF-2109-4DA9-8133-2EA4FAC4FDEAQ38469746-ABEC9769-1131-416E-BEB3-7FE4A440329FQ38472067-3A7D8548-8752-44B5-BFAA-777F6DDC59D6Q38527941-3C84538C-191F-478A-8BA3-5766F7084A0EQ38627885-4894CF8F-4D1C-4925-A582-E2ED73FEB137Q38925022-9EA4559D-88F4-4992-8987-424C35E798C1Q39271545-D4E68D28-DB94-4525-9D32-31FBDEE230A2Q44640459-384452E4-611E-4C8A-B99A-662FD132DBFEQ47355982-89490B4F-2FA9-4A49-8220-53D40EE61B37Q47432725-66721F5A-DC3A-4AA6-AF8A-42187740C329Q53121873-9D814D00-4CFA-4E96-9430-17BC6D91F198Q54863183-2BA4654C-B2F7-4BE9-B961-3645C500CEB3Q55254546-EAC96281-8EAC-44B2-88D6-F88ACBA374A5Q55263134-1392BBAA-E9FF-4F6B-9BC2-DC4B5AD0C4E6
P2860
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Masitinib in advanced gastroin ...... d controlled open-label trial.
@ast
Masitinib in advanced gastroin ...... d controlled open-label trial.
@en
Masitinib in advanced gastrointestinal stromal tumor
@nl
type
label
Masitinib in advanced gastroin ...... d controlled open-label trial.
@ast
Masitinib in advanced gastroin ...... d controlled open-label trial.
@en
Masitinib in advanced gastrointestinal stromal tumor
@nl
prefLabel
Masitinib in advanced gastroin ...... d controlled open-label trial.
@ast
Masitinib in advanced gastroin ...... d controlled open-label trial.
@en
Masitinib in advanced gastrointestinal stromal tumor
@nl
P2093
P2860
P50
P356
P1433
P1476
Masitinib in advanced gastroin ...... d controlled open-label trial.
@en
P2093
B A Van Tine
B Bui-Nguyen
C D Mansfield
F Bertucci
L Chaigneau
P2860
P304
P356
10.1093/ANNONC/MDU237
P577
2014-07-25T00:00:00Z